PT1100528E - Utilizacao de novos agentes indutores de morte celular em sinergia com os interferoes - Google Patents

Utilizacao de novos agentes indutores de morte celular em sinergia com os interferoes

Info

Publication number
PT1100528E
PT1100528E PT99936659T PT99936659T PT1100528E PT 1100528 E PT1100528 E PT 1100528E PT 99936659 T PT99936659 T PT 99936659T PT 99936659 T PT99936659 T PT 99936659T PT 1100528 E PT1100528 E PT 1100528E
Authority
PT
Portugal
Prior art keywords
synergy
inductors
interferes
new cellular
deaths
Prior art date
Application number
PT99936659T
Other languages
English (en)
Inventor
Marcel Koken
Frederique Quignon
Hugues De The
Jean-Claude Ameisen
Frederic De Bels
Original Assignee
Centre Nat Rech Scient
Inst Nat La Sante Et La Rech M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Inst Nat La Sante Et La Rech M filed Critical Centre Nat Rech Scient
Publication of PT1100528E publication Critical patent/PT1100528E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coils Or Transformers For Communication (AREA)
  • Inorganic Fibers (AREA)
  • Filters And Equalizers (AREA)
  • Peptides Or Proteins (AREA)
PT99936659T 1998-07-31 1999-07-30 Utilizacao de novos agentes indutores de morte celular em sinergia com os interferoes PT1100528E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9809886A FR2781674B1 (fr) 1998-07-31 1998-07-31 Utilisation de nouveaux agents inducteurs de mort cellulaire en synergie avec les interferons

Publications (1)

Publication Number Publication Date
PT1100528E true PT1100528E (pt) 2002-12-31

Family

ID=9529292

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99936659T PT1100528E (pt) 1998-07-31 1999-07-30 Utilizacao de novos agentes indutores de morte celular em sinergia com os interferoes

Country Status (11)

Country Link
US (1) US7217413B1 (pt)
EP (1) EP1100528B1 (pt)
JP (3) JP2002522395A (pt)
AT (1) ATE226087T1 (pt)
AU (1) AU5168099A (pt)
DE (1) DE69903559T2 (pt)
DK (1) DK1100528T3 (pt)
ES (1) ES2181461T3 (pt)
FR (1) FR2781674B1 (pt)
PT (1) PT1100528E (pt)
WO (1) WO2000007616A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ296799A0 (en) 1999-09-20 1999-10-14 Unisearch Limited A cell-membrane impermeable trivalent organoarsenical derivative and use thereof
AUPR379801A0 (en) 2001-03-19 2001-04-12 Unisearch Limited Use of a substantially cell membrane impermeable compound for treating arthritis
AUPR874601A0 (en) * 2001-11-08 2001-11-29 Unisearch Limited Selective targeting of apoptotic cells
FR2838965B1 (fr) 2002-04-26 2004-06-25 Centre Nat Rech Scient Therapie par l'arsenic du syndrome autoimmunlymphoproliferatif de type apls chez la souris comme chez l'homme
US8394422B2 (en) 2002-04-26 2013-03-12 Centre National De La Recherche Scientifique (Cnrs) Arsenic therapy for autoimmune and/or inflammatory diseases in mice and humans
US20060205771A1 (en) * 2002-09-25 2006-09-14 Mark Noble Caspase inhibitors as anticancer agents
CA2504935C (en) 2002-11-07 2012-04-10 Newsouth Innovations Pty Limited Induction of the mitochondrial permeability transition
JP2010222289A (ja) * 2009-03-23 2010-10-07 Tokyoto Igaku Kenkyu Kiko 細胞死を予防するための医薬剤
US8784797B2 (en) 2009-12-15 2014-07-22 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods, pharmaceutical compositions and kits for use in the treatment of adult T-cell leukemia/lymphoma
ES3009748T3 (en) * 2017-01-18 2025-03-31 Inst Nat Sante Rech Med Pharmaceutical compositions for the treatment patients suffering from myeloproliferative disorders
JP7336359B2 (ja) * 2019-03-13 2023-08-31 株式会社明電舎 配電系統制御装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1233476A (zh) * 1998-04-24 1999-11-03 陆道培 治疗急性白血病的药物及其制备方法
US20020001841A1 (en) * 1998-06-26 2002-01-03 Keld Kaltoft Continuous t-cell lines
EP1360311B1 (en) * 2000-08-25 2008-04-09 Aventis Pharmaceuticals Inc. Membrane penetrating peptides and uses thereof

Also Published As

Publication number Publication date
DK1100528T3 (da) 2002-11-04
WO2000007616A3 (fr) 2000-04-20
AU5168099A (en) 2000-02-28
FR2781674B1 (fr) 2002-06-28
ATE226087T1 (de) 2002-11-15
ES2181461T3 (es) 2003-02-16
US7217413B1 (en) 2007-05-15
FR2781674A1 (fr) 2000-02-04
DE69903559T2 (de) 2003-02-27
JP2011190280A (ja) 2011-09-29
EP1100528A2 (fr) 2001-05-23
DE69903559D1 (de) 2002-11-21
JP2014129404A (ja) 2014-07-10
JP2002522395A (ja) 2002-07-23
WO2000007616A2 (fr) 2000-02-17
EP1100528B1 (fr) 2002-10-16

Similar Documents

Publication Publication Date Title
TR200101764T2 (tr) Yeni bileşikler.
ZA987491B (en) Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation
EA200001245A1 (ru) КОМПОЗИЦИИ НА ОСНОВЕ ПИРРОЛО [2,3d] ПИРИМИДИНОВ И ИХ ПРИМЕНЕНИЕ
MXPA02000119A (es) Elementos mezcladores estaticos apilados.
PT1100528E (pt) Utilizacao de novos agentes indutores de morte celular em sinergia com os interferoes
IL132951A0 (en) Compounds preparation and use for transferring nucleic acids into cells
DE59709437D1 (de) Neue phenanthridine
TR200201484T2 (tr) Çeşitli hastalıkların koruyucu ve iyileştirici tedavisi için bakteriyel fajlar ile ilişkili lisleme enzimlerinin kullanımı
MX9705296A (es) Compuestos novedosos de imidazol 1,4,5-susbtituidos y el uso de los mismos para preparar composiciones para uso en terapia.
PL343462A1 (en) Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor
DK0996409T3 (da) Præparat til at forsinke hårvækst og tilsvarende anvendelse
MXPA01008465A (es) Complejos de anticuerpo de quimiocina biotinilada.
ATE368682T1 (de) Als 2f1 bezeichnetes rezeptorprotein
FR2662698B1 (pt)
TR199802649A2 (xx) Sikline ba�l� kinazlar�n inhibit�rleri i�in ba�lama e�leri.
MXPA01010403A (es) Agentes quimiotacticos e inhibidores derivados de osteopontina y usos de los mismos.
DE69920949D1 (de) Ascomycin enthaltende topische zubereitungen
TR199800302A2 (xx) Bunakl�kta kullan�ma y�nelik kombinasyon preparat�.
NZ502800A (en) The use of apoptin in determining the transforming capability of tumorigenic or tumor promoting agents
NZ503401A (en) Use of interferon-beta (IFN-B) genes for the treatment of cancer
TR200003453T2 (tr) Yeni terkipler
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
DE69424470D1 (de) Verbesserungen an zellular mobilen Funksystemen und diese betreffend
IT1128529B (it) Procedimento di metallizzazione in particolare galvanizzazione di superfici di acciaio senza la emissione di fanghi di scarico
AU9286098A (en) Agent for modifying the proliferation, functional activity and death of natural and tumoral cells